Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Murphy

Showing results (431-440 of 3,873) with videos related to

Pageof 388
Sort By:
Urology|June 1, 1984
Clinical toxicity and long-term results of Emcyt therapy for prostate cancerN H Slack, G P Murphy
Clinical Orthopaedics and Related Research|February 17, 2021
CORR Synthesis: When Should the Orthopaedic Surgeon Use Artificial Intelligence, Machine Learning, and Deep Learning?Michael P Murphy, Nicholas M Brown
Nature Reviews. Drug Discovery|November 6, 2018
Mitochondria as a therapeutic target for common pathologiesMichael P Murphy, Richard C Hartley
Molecular Reproduction and Development|August 26, 1998
Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expressionS P Murphy, T B Tomasi
Review of Surgery|July 1, 1971
Erythropoietin alterations in human renal diseaseG P Murphy, E A Mirand
The Journal of Applied Bacteriology|December 1, 1970
A comparator method of assessing bacterial plate countsR P Murphy, C G Tucker
Journal of the National Cancer Institute|April 1, 1973
A murine renal cell carcinomaG P Murphy, W J Hrushesky
Journal of the National Cancer Institute|April 1, 1974
Evaluation of chemotherapeutic agents in a new murine renal carcinoma modelW J Hrushesky, G P Murphy
Journal of Surgical Oncology|January 1, 1971
Erythropoietin and renin release by isolated perfused canine liver--kidney preparationG P Murphy, E A Mirand
New York State Journal of Medicine|April 1, 1974
Metastatic testicular carcinoma: single-agent chemotherapy (actinomycin D) in treatmentC E Merrin, G P Murphy
Pageof 388

Showing results (431-440 of 3,873) with videos related to

Sort By:
Pageof 388
Urology|June 1, 1984
Clinical toxicity and long-term results of Emcyt therapy for prostate cancerN H Slack, G P Murphy
Clinical Orthopaedics and Related Research|February 17, 2021
CORR Synthesis: When Should the Orthopaedic Surgeon Use Artificial Intelligence, Machine Learning, and Deep Learning?Michael P Murphy, Nicholas M Brown
Nature Reviews. Drug Discovery|November 6, 2018
Mitochondria as a therapeutic target for common pathologiesMichael P Murphy, Richard C Hartley
Molecular Reproduction and Development|August 26, 1998
Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expressionS P Murphy, T B Tomasi
Review of Surgery|July 1, 1971
Erythropoietin alterations in human renal diseaseG P Murphy, E A Mirand
The Journal of Applied Bacteriology|December 1, 1970
A comparator method of assessing bacterial plate countsR P Murphy, C G Tucker
Journal of the National Cancer Institute|April 1, 1973
A murine renal cell carcinomaG P Murphy, W J Hrushesky
Journal of the National Cancer Institute|April 1, 1974
Evaluation of chemotherapeutic agents in a new murine renal carcinoma modelW J Hrushesky, G P Murphy
Journal of Surgical Oncology|January 1, 1971
Erythropoietin and renin release by isolated perfused canine liver--kidney preparationG P Murphy, E A Mirand
New York State Journal of Medicine|April 1, 1974
Metastatic testicular carcinoma: single-agent chemotherapy (actinomycin D) in treatmentC E Merrin, G P Murphy
Pageof 388